Incretins: all 1,182 studies that test it

Page 3 of 12. Open to participants first (46), then studies with results posted, then the rest; newest registration first within each.

• Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 DiabetesCompletedNCT01951339Not applicableResults posted
• Two-way Crossover Study in Healthy Male and Female Subjects to Evaluate the Bioequivalence of Jentadueto®.CompletedNCT01947153Phase 1Results posted
• Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2DCompletedNCT01937598Phase 3Results posted
• A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I DiabetesCompletedNCT01928329Phase 2Results posted
• Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney TransplantCompletedNCT01928199Phase 4Results posted
• Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 DiabetesCompletedNCT01917656Phase 4Results posted
• Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and MetforminCompletedNCT01907854Phase 4Results posted
• Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)CompletedNCT01897532Phase 4Results posted
• Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 DiabetesCompletedNCT01890122Phase 3Results posted
• Effect of Chronic Incretin-based Therapy in Cystic FibrosisCompletedNCT01879228Not applicableResults posted
• A Study of LY3025876 in Participants With DiabetesCompletedNCT01870297Phase 1Results posted
• Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin TherapyCompletedNCT01859793Phase 4Results posted
• Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 DiabetesCompletedNCT01856790Early Phase 1Results posted
• The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney DiseaseCompletedNCT01847313Phase 3Results posted
• Sitagliptin Therapy in Hospitalized Patients With Type 2 DiabetesCompletedNCT01845831Phase 4Results posted
• Relative Bioavailability of 2 Fixed Dose Combinations of Linagliptin/Metformin Compared With Single TabletsCompletedNCT01845077Phase 1Results posted
• The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 DiabetesCompletedNCT01836523Phase 3Results posted
• A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 WeeksCompletedNCT01832532Phase 1/2Results posted
• Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)CompletedNCT01800968Phase 2Results posted
• Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 DiabetesCompletedNCT01798264Phase 1Results posted
• A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 DiabetesCompletedNCT01794143Phase 3Results posted
• MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptinCompletedNCT01792518Phase 3Results posted
• Pilot Study of Bydureon to Treat Diabetes in HIV-infected AdultsTerminatedNCT01791465Phase 4Results posted
• 52 Week Trial of Liraglutide in Type 1 DiabetesCompletedNCT01787916Phase 4Results posted
• Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.CompletedNCT01784965Phase 3Results posted
• RISE Adult Medication StudyCompletedNCT01779362Phase 3Results posted
• Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 DiabetesCompletedNCT01778049Phase 3Results posted
• Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft SurgeryTerminatedNCT01765270Phase 4Results posted
• A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289)CompletedNCT01760447Phase 3Results posted
• Liraglutide Versus Insulin Mono-therapy in the Closed Loop SettingCompletedNCT01755416Phase 2Results posted
• Liraglutide In Overweight Patients With Type 1 DiabetesCompletedNCT01753362Phase 3Results posted
• Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 DiabetesCompletedNCT01734785Phase 3Results posted
• Liraglutide in the Treatment of Type 1 Diabetes MellitusCompletedNCT01722266Phase 3Results posted
• Liraglutide in Type 1 DiabetesCompletedNCT01722240Phase 3Results posted
• Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC TransplantCompletedNCT01720264Phase 2Results posted
• Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 PatientsCompletedNCT01708902Phase 3Results posted
• Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation)CompletedNCT01703286Phase 1Results posted
• A Study to Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)CompletedNCT01702298Phase 3Results posted
• Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart FunctionCompletedNCT01686932Phase 4Results posted
• A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)TerminatedNCT01678820Phase 3Results posted
• The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD TherapyCompletedNCT01676116Phase 3Results posted
• Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 DiabetesCompletedNCT01664624Phase 1Results posted
• Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy ParticipantsCompletedNCT01662999Phase 1Results posted
• Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal ImpairmentCompletedNCT01620489Phase 3Results posted
• Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 DiabetesCompletedNCT01619059Phase 3Results posted
• The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin TherapyCompletedNCT01618162Phase 3Results posted
• The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 DiabetesCompletedNCT01617434Phase 3Results posted
• Contribution of Pancreatic αcells Function to Blood Glucose Regulation in Chinese Type 2 Diabetics- the Effect of Sitagliptin on Glucagon Secretion, Insulin Secretion and Insulin Resistance in Chinese Type 2 DiabeticsCompletedNCT01610154Phase 4Results posted
• The Efficacy and Safety Study in Patients With Type 2 Diabetes MellitusCompletedNCT01608724Phase 4Results posted
• Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 DiabetesCompletedNCT01606007Phase 3Results posted
• Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in HumansCompletedNCT01600703Phase 2/3Results posted
• A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254)CompletedNCT01590797Phase 3Results posted
• A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253)CompletedNCT01590771Phase 3Results posted
• Weight Loss With Exenatide TreatmentCompletedNCT01590433Phase 4Results posted
• Acute Effect of Exenatide on Brain Glucose MetabolismCompletedNCT01588418Phase 4Results posted
• A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142)CompletedNCT01582308Phase 1Results posted
• Bioequivalence of Metformin Under Fed Conditions After Administration of Linagliptin / Metformin Fixed Dose Combination Tablet and Single TabletsCompletedNCT01581931Phase 1Results posted
• Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 DiabetesCompletedNCT01572740Phase 3Results posted
• Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRICompletedNCT01562678Phase 4Results posted
• A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296)CompletedNCT01557504Phase 1Results posted
• Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep ApnoeaCompletedNCT01557166Phase 3Results posted
• Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 DiabetesCompletedNCT01554618Phase 3Results posted
• Effectiveness of Sitagliptin for HIV Insulin Resistance and InflammationCompletedNCT01552694Phase 3Results posted
• Effect of Saxagliptin Treatment on Myocardial Fat Content, and Monocyte InflammationTerminatedNCT01548651Phase 4Results posted
• Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 DiabetesCompletedNCT01541215Phase 3Results posted
• Pharmacokinetics of Fixed Dose Combination (FDC) Tablets of Linagliptin /MetforminCompletedNCT01540487Phase 1Results posted
• Sitagliptin Dose Determination StudyCompletedNCT01530178Phase 4Results posted
• Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DMTerminatedNCT01525225Phase 1Results posted
• FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)CompletedNCT01524705Phase 4Results posted
• Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and MetforminCompletedNCT01519674Phase 4Results posted
• Treatment of Diabetes After Gastric Bypass With SitagliptinCompletedNCT01512797Not applicableResults posted
• Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD AloneCompletedNCT01512108Phase 3Results posted
• Adding Liraglutide to High Dose Insulin: Breaking the CycleCompletedNCT01505673Phase 4Results posted
• Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)CompletedNCT01485614Phase 3Results posted
• Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain TumorCompletedNCT01484873Phase 2Results posted
• A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)TerminatedNCT01477853Phase 3Results posted
• Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260)CompletedNCT01462266Phase 3Results posted
• Long-term Study of Alogliptin as an Add-on to Rapid-Acting Insulin Secretagogues in Type 2 DiabetesCompletedNCT01456130Phase 3Results posted
• Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes MellitusCompletedNCT01449747Phase 4Results posted
• Effects of Exenatide on Overweight Adolescents With Prader-Willi SyndromeCompletedNCT01444898Not applicableResults posted
• Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic ControlCompletedNCT01438814Phase 4Results posted
• A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin AloneCompletedNCT01434186Phase 3Results posted
• Effect Of Exenatide Treatment on Liver Fat Content in Patients With DiabetesCompletedNCT01432405Phase 4Results posted
• A Study of LY2189265 and Sitagliptin in Participants With Type 2 DiabetesCompletedNCT01408888Phase 1Results posted
• Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105)CompletedNCT01405911Phase 2Results posted
• A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 DiabetesCompletedNCT01392573Phase 3Results posted
• Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean ParticipantsCompletedNCT01391663Phase 1Results posted
• Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and MetforminCompletedNCT01388361Phase 3Results posted
• Changes in Bone Turnover With Exposure to a GLP-1 Receptor AgonistTerminatedNCT01381926Phase 4Results posted
• Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 DiabetesCompletedNCT01378117Phase 4Results posted
• Changes in Bone Turnover With Increased Incretin Hormone ExposureTerminatedNCT01374568Phase 4Results posted
• Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)CompletedNCT01373450Phase 1Results posted
• Bioequivalence Study of Fixed-dose Combinations and Coadministered Individual Tablets of Saxagliptin/Metformin-BrazilCompletedNCT01365091Phase 1Results posted
• Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 DiabetesCompletedNCT01364584Not applicableResults posted
• Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 DiabetesCompletedNCT01342484Phase 2Results posted
• Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)CompletedNCT01340768Phase 3Results posted
• Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 DiabetesCompletedNCT01336023Phase 3Results posted
• Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 DiabetesCompletedNCT01334229Phase 3Results posted
• Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in JapanCompletedNCT01318135Phase 2/3Results posted
• Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in JapanCompletedNCT01318122Phase 2/3Results posted

← Incretins overview